Media Release » Trang Công Nghệ | Trangcongnghe.vn

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

Globe Newswire

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

Sandoz reports first quarter 2024 sales

Globe Newswire

Sandoz reports first quarter 2024 sales

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

Globe Newswire

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars

Globe Newswire

Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars

Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering

Globe Newswire

Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering

Sandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicines

Globe Newswire

Sandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicines

Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs

Globe Newswire

Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs

XEM THÊM TIN MỚI